Navigation path

Additional tools

    Profile of registrant

Pfizer Inc.

Identification number in the register: 4263301811-33
Registration date: 18/12/2008 10:25:52

The information on this entity was last modified on: 02/02/2015 15:30:14
The date of the last annual update was: 02/02/2015 15:30:14
Next update due latest on: 02/02/2016

    Registrant : Organisation or self-employed individual

Pfizer Inc.



    Section of registration

II - In-house lobbyists and trade/business/professional associations

Companies & groups

    Contact details

East 42nd Street, 235
New York NY 10017

(+1) 2127332323

Boulevard de la Plaine 17
Brussels 1050

(+32) 25546211

    Person with legal responsibility

Mr  Ian C. Read


    Person in charge of EU relations

Ms  Eva Grut-Aandahl

Head of EU Office

    Goals / remit

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In 2014, Pfizer's revenue was 49,6bn, with approx. 10% invested in research and development.To learn more, please visit us at


    Specific activities covered by the Register

healthcare and pharmaceutical legislation, trade & IP, competition, taxation, environment, social legislation

None foreseen




EU expert group on rare diseases



Pharmaceuticals, healthcare, innovation and research, intellectual property, business competitiveness, trade, environment

    Number of persons involved in the activities described in the box above

50%: 4   25%: 3



4 colleagues are full-time engaged in the Brussels office and will spend approx. 50% of their time on EU affairs. 3 colleagues spend about 25% of their time, and a few more colleagues spend between 0-5% of their time.

    Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Matthew Thomas CLAY 09/01/2015 07/01/2016
EVA GRUT AANDAHL 19/02/2015 17/02/2016
HEIKE GALBRAITH 25/02/2015 23/02/2016
CHARLES FAID 25/02/2015 18/02/2016

    Fields of interest

  • Competition
  • Consumer Affairs
  • Customs
  • Economic and Financial Affairs
  • Enlargement
  • Enterprise
  • Environment
  • External Relations
  • General and Institutional Affairs
  • Humanitarian Aid
  • Internal Market
  • Justice and Fundamental Rights
  • Public Health
  • Research and Technology
  • Trade

    Membership and affiliation


Pfizer is a member of: EFPIA, EBE, Vaccines Europe, EuropaBio, AESGP, Amcham EU, BusinessEurope, TPN, TABC, AECA

    Financial data

11/2013  -  11/2014

700,000 € - 799,999 €

No funding received from the EU institutions during the last closed financial year.

This estimate is based on the pro rata salary costs of Pfizer staff involved in interest representation to the European institutions, based on the proportion of employee time spent on these activities. A proportion of overheads for our Brussels office is included in the estimate on the same basis, as well as other costs required in the November 2014 guideline.

    Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.

The organisation has also declared to be bound to the following other Code:
Internal Pfizer FCPA Code and Compliance, EFPIA Codes